AGX Form 144: Insider to Sell 11,802 Shares Worth $3.23M
Argan, Inc. (AGX) submitted a Form 144 notifying the SEC of a proposed sale of 11,802 common shares acquired by stock option exercise on 06/09/2025.
Rhea-AI Filing Summary
Argan, Inc. (AGX) submitted a Form 144 notifying the SEC of a proposed sale of 11,802 common shares acquired by stock option exercise on 06/09/2025. The filing lists the broker as Fidelity Brokerage Services LLC and shows an aggregate market value of $3,228,909.00 based on outstanding shares of 13,811,575. The approximate date of sale is 09/29/2025 on the NYSE. The filer certifies there is no undisclosed material adverse information and reports no sales of issuer securities in the past three months.
Positive
- Insider exercised stock options on 06/09/2025, demonstrating option realization
- Planned sale details disclosed: 11,802 shares for an aggregate market value of $3,228,909.00 through Fidelity on NYSE (09/29/2025)
Negative
- None.
Insights
TL;DR: Routine insider notice: option exercise followed by planned sale of 11,802 shares worth $3.23M; neutral to market absent other disclosures.
The Form 144 documents an insider exercise of stock options on 06/09/2025 and a proposed sale of those shares through Fidelity on 09/29/2025. The filing provides specific quantities and an aggregate market value of $3,228,909.00. There are no reported sales in the prior three months and the filer affirms no undisclosed material adverse information. This is a standard regulatory disclosure enabling sale under Rule 144 and, on its face, does not introduce new operational or financial data about the company.
TL;DR: Disclosure meets Rule 144 requirements for an officer/director/affiliate sale; compliance-focused and not inherently material.
The filing identifies the nature of acquisition as a stock option exercise and names the broker and sale date. It includes the statutory representation regarding material information and shows no recent sales by the reporting person. As a governance disclosure, it documents an intended transfer of shares by a person subject to insider-sale rules; absent further context about role or pattern of sales, this is a compliance filing rather than a governance event that implies misconduct or material change.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Form 144 for AGX disclose?
Who is the broker handling the proposed AGX sale?
Does the filing report any other sales in the past three months for the filer?
Does the filer assert any undisclosed material information about AGX?
AI-generated analysis. How Rhea-AI works. Not financial advice.